Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors

Primary and secondary adrenal insufficiency (AI) are commonly known immune-related adverse events following treatment with immune checkpoint inhibitors (ICIs), and are clinically relevant due to their morbidity and potential mortality. For this reason, upfront identification of patients susceptible...

Descripción completa

Detalles Bibliográficos
Autores principales: Helderman, N.C., Lucas, M.W., Blank, C.U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014276/
https://www.ncbi.nlm.nih.gov/pubmed/36937704
http://dx.doi.org/10.1016/j.iotech.2023.100374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014276/
https://www.ncbi.nlm.nih.gov/pubmed/36937704
http://dx.doi.org/10.1016/j.iotech.2023.100374

Ejemplares similares